Neurocrine Biosciences (NBIX) Nyanmɛn Kpɛn
Nɛnɛn kpanlan$138.08Kpɛn 25 Sep 2026 19:59 UTC
Chɛ̀ndʒ-0.62%
AI bɛ́nɛ́nɛ́: NBIX
AI bɛ sɔhɛn sɛn na ɛbɛ yɛ a ɛwɔ nna a ɛdi akyi, nnwɔtwe no awieeɛ ne bosome no awieeɛ. Nsakraeɛ no yɛ nea wɔhwɛ firi sika a ɛwɔ hɔ seesei. Eyinom yɛ nkyɛmu nhyehyɛeɛ, ɛnyɛ nkyɛmu a wɔde bɛyɛ adwuma.
Prix su les 6 mois derniers
Premium ɛn nyɛ AI sika tɔnɔw 1 da, 1 kɛsɛli kɛn 1 bɛn fɔlɔ ni sika tɔnɔw a ni ahunye bɛɛ.
Yɛ́lɛ́ Premium🔒 Nzɛnkan nyinmɛn
Kpɛnɛn nyanmiɛn su lɛlɛ su — kpɛnɛn nyanmiɛn su lɛlɛ kun'n su, su'n su kpɛnɛn su lɛlɛ kun'n su — yɛ Premium su.
Yɛ́lɛ́ PremiumNyanmiɛn nɛnɛn
Neurocrine Biosciences, Inc. (NBIX) researches and develops therapeutic agents for the treatment of psycho-neurological, neuroinflammatory, and neurodegenerative diseases and disorders, as well as for neuroses, depression, Alzheimer’s disease, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
